Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
Background: Currently, the immunogenicity of influenza vaccines is assessed by detecting an increase of hemagglutination inhibition (HI) antibodies. As neuraminidase (NA)-based immunity may be significant in protecting against influenza infection, detection of neuraminidase inhibiting (NI) antibodie...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2020-05-01
|
| Sarja: | Antibodies |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2073-4468/9/2/20 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|